Chapter 23. The Current Status of Iron Chelation Therapy
- 1 January 1978
- book chapter
- Published by Elsevier
- Vol. 13, 219-226
- https://doi.org/10.1016/s0065-7743(08)60626-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Healing of Duodenal Ulcer with an Antacid RegimenNew England Journal of Medicine, 1977
- Hydroxamic acid polymers. II. Design of a polymeric chelating agent for ironJournal of Polymer Science: Polymer Chemistry Edition, 1976
- dl‐α‐TOCOPHEROL, IRON, AND LIPOFUSCIN IN THALASSEMIA*Annals of the New York Academy of Sciences, 1974
- COMBINED LONG‐TERM TREATMENT OF HEMOSIDEROSIS WITH DESFERRIOXAMINE AND DTPA IN HOMOZYGOUS β‐THALASSEMIAAnnals of the New York Academy of Sciences, 1974
- Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical ProgressBMJ, 1974
- Absorption of Inorganic Iron in ThalassaemiaBritish Journal of Haematology, 1967
- Mechanisms of lipid peroxide formation in tissues Role of metals and haematin proteins in the catalysis of the oxidation of unsaturated fatty acidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1965
- Products of “Low-iron Fermentation” with Bacillus subilis: Isolation, Characterization and Synthesis of 2,3-Dihydroxybenzoylglycine1,2Journal of the American Chemical Society, 1958
- Chelating Tendencies of N,N'-Ethylenebis-[2-(o-hydroxyphenyl)]-glycineJournal of the American Chemical Society, 1958